Silver Diamine Fluoride(SDF) Versus SDF Combined With Sodium Fluoride Varnish in the Arrest of Early Childhood Caries

July 18, 2023 updated by: Enas Belal, Alexandria University

Comparison of the Effectiveness of Silver Diamine Fluoride Versus Silver Diamine Fluoride Combined With Sodium Fluoride Varnish in the Arrest of Early Childhood Caries: A Randomised Controlled Clinical Trial

Early childhood caries (ECC) is the most common chronic childhood disease worldwide. Early restorative intervention may treat the disease but this is often difficult especially with uncooperative children so it may be left untreated. Remineralization of affected dentin using silver diamine fluoride (SDF) can arrest these lesions.

This trial aims to compare the effectiveness of 38% SDF solution versus 38% SDF solution with 5% sodium fluoride (NaF) varnish after six months in arresting ECC lesions.

Study Overview

Status

Completed

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

220

Phase

  • Phase 3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt, 21514
        • Faculty Of Dentistry Alexandria University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 4 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. Children ≤ 4 years old.
  2. The presence of at least one carious lesion on a primary tooth, with scores 3 and higher (according to the International Detection and Assessment System- ICDAS II, Appendix 1, Table 1), detected by visual examination.
  3. The Carious lesion has to be active according to Lesion Activity criteria of coronal caries of ICDAS II.
  4. Parental consent for children's participation in the study.

Exclusion Criteria:

  1. Children reporting spontaneous or elicited pain from caries, or showing any signs of pulpal infection, swelling and/or abscess.
  2. Children showing a definite negative behavior (Score 1 Frankel's classification) during clinical examination.
  3. Allergy or sensitivity to silver or any of the materials included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: SDF+NaF
Silver Diamine fluoride 38% (Applied biannually)+ Sodium Fluoride Varnish 5% (Applied every 3 months)
Silver Diamine Fluoride 38% (Applied bianually)
Sodium Fluoride Varnish (5%) (Applied at baseline and after 3 months)
Active Comparator: SDF
Silver Diamine fluoride 38% (Applied biannually)
Silver Diamine Fluoride 38% (Applied bianually)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The percentage of arrested carious lesions
Time Frame: 6 months
For cavitated dentine caries lesions diagnosed as ICDAS code 5 or 6, visual inspection and tactile detection using a 0.5mm ball-ended Community Periodontal Index (CPI) probe without radiograph examination will be used for assessing caries activity according to Lesion Activity criteria of ICDAS II. If a wall or floor of the lesion is soft and easily penetrated by the probe using light force, then it will be diagnosed as active. A lesion with all surfaces being hard and smooth will be diagnosed as arrested caries .For a moderate caries lesion with no visible dentine (ICDAS code 3 or 4) at baseline, it will be classified as arrested caries at follow-up examination if the lesion did not progress to become a cavitated lesion with visible dentine (ICDAS code 5 or 6). Five tooth surfaces (buccal, lingual, mesial, distal and occlusal) will be examined in each posterior tooth and 4 tooth surfaces (labial, lingual, mesial and distal) in each anterior tooth.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Caries Increment (number of new caries lesions)
Time Frame: 6 months
New caries lesions will be assessed through visual and tactile inspection using the World Health Organization (WHO) criteria for caries diagnosis. Full mouth examination will be conducted with the aid of a WHO CPI probe, and a disposable dental mirror. Five tooth surfaces (buccal, lingual, mesial, distal and occlusal) will be examined in each posterior tooth and 4 tooth surfaces (labial, lingual, mesial and distal) in each anterior tooth to assess the caries increment using the decayed, missing (due to caries), and filled primary tooth index per surface (dmfs).
6 months
Parental satisfaction with SDF application
Time Frame: Baseline and at 6 months
Parents will be asked If SDF Application is an easy process. Answers will be on a 5 point Likert scale (Strongly agree, Agree Neutral , Disagree, Strongly disagree).
Baseline and at 6 months
Parental satisfaction with SDF application
Time Frame: Baseline and at 6 months
Parents will be asked if they are comfortable with discoloration of cavities after SDF placement, Answers will be on a 5 point Likert scale (Strongly agree, Agree Neutral , Disagree, Strongly disagree).
Baseline and at 6 months
Parental satisfaction with SDF application
Time Frame: Baseline and at 6 months
Parents will be asked If SDF application was pain free for their child .Answers will be on a 5 point Likert scale (Strongly agree, Agree Neutral , Disagree, Strongly disagree).
Baseline and at 6 months
Parental satisfaction with SDF application
Time Frame: Baseline and at 6 months
Parents will be asked if The taste of SDF was acceptable to their child.Answers will be on a 5 point Likert scale (Strongly agree, Agree Neutral , Disagree, Strongly disagree).
Baseline and at 6 months
Adverse effects reported after application of the interventions
Time Frame: Baseline and at 6 months

Parents will be asked if their child experienced tooth or gum pain after application of the material.

(Yes/No) Question

Baseline and at 6 months
Adverse effects reported after application of the interventions
Time Frame: Baseline and at 6 months

The clinician will observe if gum swelling occurred after application of the material.

(Yes/No) Question

Baseline and at 6 months
Adverse effects reported after application of the interventions
Time Frame: Baseline and at 6 months

The clinician will observe if gum bleaching occurred after application of the material.

(Yes/No) Question

Baseline and at 6 months
Adverse effects reported after application of the interventions
Time Frame: Baseline and at 6 months

Systemic toxicity (nausea, vomiting, generalised discomfort) will be assesses by the clinician at the time of application and by asking the parents one week later.

(Yes/No) Question

Baseline and at 6 months
Adverse effects reported after application of the interventions
Time Frame: Baseline and at 6 months
Black staining of each lesion will be clinically observed and recorded (yes/no).
Baseline and at 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Enas B Abdellatif, Bachelor, Alexandria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

March 30, 2023

Study Completion (Actual)

April 30, 2023

Study Registration Dates

First Submitted

November 17, 2022

First Submitted That Met QC Criteria

November 29, 2022

First Posted (Actual)

December 8, 2022

Study Record Updates

Last Update Posted (Actual)

July 19, 2023

Last Update Submitted That Met QC Criteria

July 18, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Other Study ID Numbers

  • 0272-07/2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

Yes

product manufactured in and exported from the U.S.

Yes

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Early Childhood Caries

Clinical Trials on SDF

3
Subscribe